Selected research
Industry Growth & Trends
Global Biologics Development Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Biologics Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Biologics Development Service market include Meso Scale Discovery, Patheon, Immunologix, GenScript, Promega, Recibiopharm, Alcami Biologics, Leadgene Biomedical and Samsung Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Biologics Development Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biologics Development Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologics Development Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologics Development Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biologics Development Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biologics Development Service Market by Company
Meso Scale Discovery
Patheon
Immunologix
GenScript
Promega
Recibiopharm
Alcami Biologics
Leadgene Biomedical
Samsung Biologics
Lonza
ImmunoGen
Seattle Genetics
Roche
Takeda
Biologics Development Service Segment by Type
Vaccine
Blood and Blood Components
Tissue and Recombinant Therapeutic Proteins
Others
Biologics Development Service Segment by Application
Tumor Treatment
Chronic Disease Treatment
Enzyme and Hormone Deficiencies
Others
Biologics Development Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologics Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Development Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biologics Development Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccine
- Blood and Blood Components
- Tissue and Recombinant Therapeutic Proteins
- Others
Applications
- Tumor Treatment
- Chronic Disease Treatment
- Enzyme and Hormone Deficiencies
- Others
Companies covered
- Meso Scale Discovery
- Patheon
- Immunologix
- GenScript
- Promega
- Recibiopharm
- Alcami Biologics
- Leadgene Biomedical
- Samsung Biologics
- Lonza
- ImmunoGen
- Seattle Genetics
- Roche
- Takeda
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biologics Development Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biologics Development Service Market Size by Region (2021-2032)
- 1.4.1 Global Biologics Development Service Market Size by Region (2021-2026)
- 1.4.2 Global Biologics Development Service Market Size by Region (2027-2032)
- 1.5 Key Regions Biologics Development Service Market Size (2021-2032)
- 1.5.1 North America Biologics Development Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biologics Development Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biologics Development Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biologics Development Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biologics Development Service Market Size Growth Rate (2021-2032)
2 Biologics Development Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Vaccine
- 2.1.2 Blood and Blood Components
- 2.1.3 Tissue and Recombinant Therapeutic Proteins
- 2.1.4 Others
- 2.2 Global Biologics Development Service Market Size by Type
- 2.2.1 Global Biologics Development Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biologics Development Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biologics Development Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biologics Development Service Market Size by Regions
- 2.3.1 North America Biologics Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biologics Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biologics Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biologics Development Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biologics Development Service Market Size Breakdown by Type (2021-2026)
3 Biologics Development Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Tumor Treatment
- 3.1.2 Chronic Disease Treatment
- 3.1.3 Enzyme and Hormone Deficiencies
- 3.1.4 Others
- 3.2 Global Biologics Development Service Market Size by Application
- 3.2.1 Global Biologics Development Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biologics Development Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biologics Development Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biologics Development Service Market Size by Regions
- 3.3.1 North America Biologics Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biologics Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biologics Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biologics Development Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biologics Development Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biologics Development Service Industry Trends
- 4.2 Biologics Development Service Industry Drivers
- 4.3 Biologics Development Service Industry Opportunities and Challenges
- 4.4 Biologics Development Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biologics Development Service Revenue (2021-2026)
- 5.2 Global Biologics Development Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biologics Development Service Key Company Headquarters & Area Served
- 5.4 Global Biologics Development Service Company, Product Type & Application
- 5.5 Global Biologics Development Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biologics Development Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biologics Development Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Biologics Development Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Meso Scale Discovery
- 6.1.1 Meso Scale Discovery Company Information
- 6.1.2 Meso Scale Discovery Business Overview
- 6.1.3 Meso Scale Discovery Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Meso Scale Discovery Biologics Development Service Product Portfolio
- 6.1.5 Meso Scale Discovery Recent Developments
- 6.2 Patheon
- 6.2.1 Patheon Company Information
- 6.2.2 Patheon Business Overview
- 6.2.3 Patheon Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Patheon Biologics Development Service Product Portfolio
- 6.2.5 Patheon Recent Developments
- 6.3 Immunologix
- 6.3.1 Immunologix Company Information
- 6.3.2 Immunologix Business Overview
- 6.3.3 Immunologix Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Immunologix Biologics Development Service Product Portfolio
- 6.3.5 Immunologix Recent Developments
- 6.4 GenScript
- 6.4.1 GenScript Company Information
- 6.4.2 GenScript Business Overview
- 6.4.3 GenScript Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 GenScript Biologics Development Service Product Portfolio
- 6.4.5 GenScript Recent Developments
- 6.5 Promega
- 6.5.1 Promega Company Information
- 6.5.2 Promega Business Overview
- 6.5.3 Promega Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Promega Biologics Development Service Product Portfolio
- 6.5.5 Promega Recent Developments
- 6.6 Recibiopharm
- 6.6.1 Recibiopharm Company Information
- 6.6.2 Recibiopharm Business Overview
- 6.6.3 Recibiopharm Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Recibiopharm Biologics Development Service Product Portfolio
- 6.6.5 Recibiopharm Recent Developments
- 6.7 Alcami Biologics
- 6.7.1 Alcami Biologics Company Information
- 6.7.2 Alcami Biologics Business Overview
- 6.7.3 Alcami Biologics Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Alcami Biologics Biologics Development Service Product Portfolio
- 6.7.5 Alcami Biologics Recent Developments
- 6.8 Leadgene Biomedical
- 6.8.1 Leadgene Biomedical Company Information
- 6.8.2 Leadgene Biomedical Business Overview
- 6.8.3 Leadgene Biomedical Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Leadgene Biomedical Biologics Development Service Product Portfolio
- 6.8.5 Leadgene Biomedical Recent Developments
- 6.9 Samsung Biologics
- 6.9.1 Samsung Biologics Company Information
- 6.9.2 Samsung Biologics Business Overview
- 6.9.3 Samsung Biologics Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Samsung Biologics Biologics Development Service Product Portfolio
- 6.9.5 Samsung Biologics Recent Developments
- 6.10 Lonza
- 6.10.1 Lonza Company Information
- 6.10.2 Lonza Business Overview
- 6.10.3 Lonza Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Lonza Biologics Development Service Product Portfolio
- 6.10.5 Lonza Recent Developments
- 6.11 ImmunoGen
- 6.11.1 ImmunoGen Company Information
- 6.11.2 ImmunoGen Business Overview
- 6.11.3 ImmunoGen Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 ImmunoGen Biologics Development Service Product Portfolio
- 6.11.5 ImmunoGen Recent Developments
- 6.12 Seattle Genetics
- 6.12.1 Seattle Genetics Company Information
- 6.12.2 Seattle Genetics Business Overview
- 6.12.3 Seattle Genetics Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Seattle Genetics Biologics Development Service Product Portfolio
- 6.12.5 Seattle Genetics Recent Developments
- 6.13 Roche
- 6.13.1 Roche Company Information
- 6.13.2 Roche Business Overview
- 6.13.3 Roche Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Roche Biologics Development Service Product Portfolio
- 6.13.5 Roche Recent Developments
- 6.14 Takeda
- 6.14.1 Takeda Company Information
- 6.14.2 Takeda Business Overview
- 6.14.3 Takeda Biologics Development Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Takeda Biologics Development Service Product Portfolio
- 6.14.5 Takeda Recent Developments
7 North America
- 7.1 North America Biologics Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biologics Development Service Market Size by Country (2021-2026)
- 7.3 North America Biologics Development Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biologics Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biologics Development Service Market Size by Country (2021-2026)
- 8.3 Europe Biologics Development Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biologics Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biologics Development Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biologics Development Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biologics Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biologics Development Service Market Size by Country (2021-2026)
- 10.3 South America Biologics Development Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biologics Development Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biologics Development Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biologics Development Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst